Search

Search Constraints

You searched for: Author/Creator Valent, Peter

Search Results

1. A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens. Issue 12 (3rd October 2019)

2. A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML. (March 2019)

3. A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1. Issue 5 (4th May 2018)

4. A Phl p 7‐specific IgG4 antibody inhibits allergic patients IgE cross‐reactivity to allergens from the EF‐hand family: importance of affinity and degree of cross‐reactivity. (17th March 2014)

5. A randomized, open‐label, phase I/II trial to investigate the maximum tolerated dose of the Polo‐like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia. (16th August 2013)

6. A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes. Issue 1 (18th February 2022)

7. Accuracy, realism and general applicability of European forest models. (19th September 2022)

8. Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells. (August 2020)

9. Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes. (February 2019)